CYB5D2 and neoplasm: While the association with above genomic alterations suggest mechanisms contributing to CYB5D2-derived tumor suppression in breast cancer, the potential mechanisms underlying the co-occurrence and mutual exclusion of CYB5D2 expression with the above gene mutations are likely complex.